A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density
Nasa Sinnott-Armstrong and colleagues identify a pleiotropic risk locus at 3q21 that is associated with type 2 diabetes (T2D) and greater bone mineral density (BMD) and its associated cell-autonomous mechanisms in adipocytes and osteoblasts. Together, these findings provide a possible explanation fo...
Auteurs principaux: | Sinnott-Armstrong, N, Sousa, IS, Laber, S, Rendina-Ruedy, E, Nitter Dankel, SE, Ferreira, T, Mellgren, G, Karasik, D, Rivas, M, Pritchard, J, Guntur, AR, Cox, RD, Lindgren, CM, Hauner, H, Sallari, R, Rosen, CJ, Hsu, YH, Lander, ES, Kiel, DP, Claussnitzer, M |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Elsevier BV
2021
|
Accès en ligne: | https://hdl.handle.net/1721.1/135273 |
Documents similaires
-
A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density
par: Sinnott-Armstrong, Nasa, et autres
Publié: (2022) -
Pleiotropic effects of trimetazidine
par: O. V. Romashchenko, et autres
Publié: (2013-08-01) -
Pleiotropic effects of ipragliflozin
par: Nina A. Petunina, et autres
Publié: (2023-04-01) -
A distribution-centered approach for analyzing human adipocyte size estimates and their association with obesity-related traits and mitochondrial function
par: Honecker, J, et autres
Publié: (2021) -
PLEIOTROPIC EFFECTS OF VITAMIN D
par: O. M. Drapkina, et autres
Publié: (2016-05-01)